Trial intelligence / Profile preview

Diquafosol vs Hyaluronic Acid for Dry Eye After LASIK

NCT07097922Not yet recruiting

Sponsor
He Eye Hospital
Start
Aug 2025
Primary completion
May 2026
Modality
Small Molecules
01

Overview

Randomised trial of diquafosol in dry eye syndrome (DED) (2 arms), sponsored by He Eye Hospital. Primary endpoint: Non-invasive tear break-up time at week 24. Planned start Aug 2025; status: not yet recruiting.

02

Drugs

diquafosol
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT07097922.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07097922.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call